Literature DB >> 18242513

The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.

Nancy M Joseph1, Jack T Mosher, Johanna Buchstaller, Paige Snider, Paul E McKeever, Megan Lim, Simon J Conway, Luis F Parada, Yuan Zhu, Sean J Morrison.   

Abstract

Neurofibromatosis is caused by the loss of neurofibromin (Nf1), leading to peripheral nervous system (PNS) tumors, including neurofibromas and malignant peripheral nerve sheath tumors (MPNSTs). A long-standing question has been whether these tumors arise from neural crest stem cells (NCSCs) or differentiated glia. Germline or conditional Nf1 deficiency caused a transient increase in NCSC frequency and self-renewal in most regions of the fetal PNS. However, Nf1-deficient NCSCs did not persist postnatally in regions of the PNS that developed tumors and could not form tumors upon transplantation into adult nerves. Adult P0a-Cre+Nf1(fl/-) mice developed neurofibromas, and Nf1(+/-)Ink4a/Arf(-/-) and Nf1/p53(+/-) mice developed MPNSTs, but NCSCs did not persist postnatally in affected locations in these mice. Tumors appeared to arise from differentiated glia, not NCSCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242513      PMCID: PMC2566828          DOI: 10.1016/j.ccr.2008.01.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  46 in total

1.  The transcription factor Sox10 is a key regulator of peripheral glial development.

Authors:  S Britsch; D E Goerich; D Riethmacher; R I Peirano; M Rossner; K A Nave; C Birchmeier; M Wegner
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

2.  Mouse models of tumor development in neurofibromatosis type 1.

Authors:  K Cichowski; T S Shih; E Schmitt; S Santiago; K Reilly; M E McLaughlin; R T Bronson; T Jacks
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

5.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

6.  Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.

Authors:  N E Sharpless; N Bardeesy; K H Lee; D Carrasco; D H Castrillon; A J Aguirre; E A Wu; J W Horner; R A DePinho
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

7.  Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

Authors:  M Giovannini; E Robanus-Maandag; M van der Valk; M Niwa-Kawakita; V Abramowski; L Goutebroze; J M Woodruff; A Berns; G Thomas
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

8.  Diverse differentiation in malignant peripheral nerve sheath tumours associated with neurofibromatosis-1: an immunohistochemical and ultrastructural study.

Authors:  A Takeuchi; S Ushigome
Journal:  Histopathology       Date:  2001-09       Impact factor: 5.087

9.  Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.

Authors:  Dana King; Genyan Yang; Mary Ann Thompson; Scott W Hiebert
Journal:  Oncogene       Date:  2002-07-25       Impact factor: 9.867

10.  Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.

Authors:  Huarui Zheng; Lou Chang; Neha Patel; Jiong Yang; Lori Lowe; Dennis K Burns; Yuan Zhu
Journal:  Cancer Cell       Date:  2008-02       Impact factor: 31.743

View more
  73 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

Review 2.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 3.  Neurological disorders and the potential role for stem cells as a therapy.

Authors:  Paul R Sanberg; David J Eve; L Eduardo Cruz; Cesar V Borlongan
Journal:  Br Med Bull       Date:  2012-02-21       Impact factor: 4.291

Review 4.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 5.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

Review 6.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

7.  MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

Authors:  Walter J Jessen; Shyra J Miller; Edwin Jousma; Jianqiang Wu; Tilat A Rizvi; Meghan E Brundage; David Eaves; Brigitte Widemann; Mi-Ok Kim; Eva Dombi; Jessica Sabo; Atira Hardiman Dudley; Michiko Niwa-Kawakita; Grier P Page; Marco Giovannini; Bruce J Aronow; Timothy P Cripe; Nancy Ratner
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

Review 8.  Targeting cancer stem cells in cancer prevention and therapy.

Authors:  Prithi Rajan; Roopa Srinivasan
Journal:  Stem Cell Rev       Date:  2008-07-29       Impact factor: 5.739

9.  What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers.

Authors:  Joseph L Kissil; Jaishri O Blakeley; Rosalie E Ferner; Susan M Huson; Michel Kalamarides; Victor-Felix Mautner; Frank McCormick; Helen Morrison; Roger Packer; Vijaya Ramesh; Nancy Ratner; Katherine A Rauen; David A Stevenson; Kim Hunter-Schaedle; Kathryn North
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

10.  Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.

Authors:  Arun Padmanabhan; Jeong-Soo Lee; Fraz A Ismat; Min Min Lu; Nathan D Lawson; John P Kanki; A Thomas Look; Jonathan A Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.